Janux Therapeutics Inc (JANX)
48.75
+2.25
(+4.84%)
USD |
NASDAQ |
Nov 22, 15:04
Janux Therapeutics Enterprise Value: 1.782B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.782B |
| November 20, 2024 | 1.911B |
| November 19, 2024 | 1.914B |
| November 18, 2024 | 1.867B |
| November 15, 2024 | 1.901B |
| November 14, 2024 | 2.024B |
| November 13, 2024 | 2.071B |
| November 12, 2024 | 2.115B |
| November 11, 2024 | 2.159B |
| November 08, 2024 | 2.172B |
| November 07, 2024 | 2.187B |
| November 06, 2024 | 2.223B |
| November 05, 2024 | 2.243B |
| November 04, 2024 | 2.274B |
| November 01, 2024 | 2.189B |
| October 31, 2024 | 2.168B |
| October 30, 2024 | 2.270B |
| October 29, 2024 | 2.179B |
| October 28, 2024 | 2.187B |
| October 25, 2024 | 2.137B |
| October 24, 2024 | 2.132B |
| October 23, 2024 | 2.050B |
| October 22, 2024 | 2.105B |
| October 21, 2024 | 1.984B |
| October 18, 2024 | 1.960B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.949B |
| October 16, 2024 | 1.928B |
| October 15, 2024 | 2.102B |
| October 14, 2024 | 1.925B |
| October 11, 2024 | 1.935B |
| October 10, 2024 | 1.813B |
| October 09, 2024 | 1.749B |
| October 08, 2024 | 1.693B |
| October 07, 2024 | 1.653B |
| October 04, 2024 | 1.698B |
| October 03, 2024 | 1.654B |
| October 02, 2024 | 1.616B |
| October 01, 2024 | 1.671B |
| September 30, 2024 | 1.720B |
| September 27, 2024 | 1.766B |
| September 26, 2024 | 1.786B |
| September 25, 2024 | 1.852B |
| September 24, 2024 | 1.888B |
| September 23, 2024 | 1.975B |
| September 20, 2024 | 1.972B |
| September 19, 2024 | 1.961B |
| September 18, 2024 | 1.874B |
| September 17, 2024 | 1.934B |
| September 16, 2024 | 1.956B |
| September 13, 2024 | 1.962B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-79.73M
Minimum
Nov 09 2023
2.707B
Maximum
May 03 2024
622.99M
Average
307.26M
Median
Enterprise Value Benchmarks
| Dynavax Technologies Corp | 1.084B |
| Krystal Biotech Inc | 4.654B |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -28.06M |
| Revenue (Quarterly) | 0.439M |
| Total Expenses (Quarterly) | 36.28M |
| EPS Diluted (Quarterly) | -0.51 |
| Profit Margin (Quarterly) | -6.39K% |
| Earnings Yield | -2.38% |
| Normalized Earnings Yield | -2.379 |